This webpage contains legacy information. The product is either no longer available from the supplier or has been delisted at Labome.
product summary
company name :
Bio-Rad
other brands :
Biogenesis, Serotec, AbD Serotec, Oxford Biotechnology
product type :
antibody
product name :
GOAT ANTI HUMAN PAI-1
catalog :
AHP1100
quantity :
0.1 mg
clonality :
polyclonal
host :
domestic goat
conjugate :
nonconjugated
reactivity :
human
application :
western blot, ELISA
product information
Entity Category :
Antibodies
Product Code :
AHP1100
Description :
GOAT ANTI HUMAN PAI-1
Specificity :
PAI-1
Target Species :
Human
Host :
Goat
Format :
Purified
Isotypes :
Polyclonal IgG
Applications :
E, P*, WB
Application Types :
ELISA, Western Blotting, Immunohistology - Paraffin
Cross Reactivities :
Chimpanzee, Dog
Quantity :
0.1 mg
Quantity Value :
0.1 mg
Quantity Type :
mg
GO Accessions :
GO:0005886, GO:0001300, GO:0002020, GO:0002576, GO:0004252, GO:0004867, GO:0005615, GO:0050829, GO:0010469, GO:0010757, GO:0014912, GO:0030168, GO:0031012, GO:0031093, GO:0032757, GO:0033629, GO:0035491, GO:0042730, GO:0043066, GO:0045766, GO:0048260, GO:0051918, GO:0061044, GO:0070887, GO:0071222, GO:0090026, GO:2000098
GO Terms :
activation of angiogenesis, activation of interleukin-8 production, activation of receptor mediated endocytosis, bacterial inner membrane, blood coagulation factor activity, blood coagulation, platelet activation, cell membrane, cellular response to endotoxin, cellular response to LPS, chronological cell ageing, cytoplasmic membrane, defence response to Gram-negative bacteria, defence response to Gram-negative bacterium, defense response to Gram-negative bacteria, down regulation of apoptosis, down regulation of fibrinolysis, downregulation of apoptosis, down-regulation of apoptosis, downregulation of fibrinolysis, down-regulation of fibrinolysis, GO:0005904, Gram-negative antibacterial peptide activity, inhibition of apoptosis, inhibition of fibrinolysis, inhibition of plasminogen activation, inner endospore membrane, intercellular space, juxtamembrane, negative regulation of cell adhesion mediated by integrin complex, plasma membrane lipid bilayer, plasmalemma, platelet alpha-granule lumen, platelet exocytosis, positive regulation of IL-8 production, positive regulation of receptor mediated endocytosis, serine protease inhibitor activity, serine proteinase inhibitor activity, serpin activity, stimulation of angiogenesis, stimulation of interleukin-8 production, stimulation of receptor mediated endocytosis, up regulation of angiogenesis, up regulation of interleukin-8 production, up regulation of receptor mediated endocytosis, upregulation of angiogenesis, up-regulation of angiogenesis, up-regulation of interleukin-8 production, upregulation of interleukin-8 production, upregulation of receptor mediated endocytosis, up-regulation of receptor mediated endocytosis
Uniprot Accessions :
P05121
Gene :
SERPINE1
GeneID URL :
http://www.ncbi.nlm.nih.gov/sites/entrez?Db=gene&Cmd=ShowDetailView&TermToSearch=5054
Published Synonyms :
SERPINE1
EntityFormats :
Purified
UNSPSC :
41116161
Concentration :
IgG concentration 0.5 mg/ml
Product Form :
Purified IgG - liquid
PrimarySecondary :
Primary
NotForSaleInCountries :
Canada
company information
Bio-Rad
Endeavour House, Langford Business Park
Langford Lane, Kidlington
OXON, OX5 1GE
antibody_sales_uk@bio-rad.com
https://www.bio-rad-antibodies.com
1 800 265 7376 (North America)
44 (0)1865 852 700 (Rest of World)
headquarters: UK
Bio-Rad is one of the world's leading antibody manufacturers, offering over 12,000 antibodies and related reagents for a focused range of research areas such as immunology, cancer, veterinary research and cell biology through its antibody experts formerly known as AbD Serotec.
The range includes apoptosis kits, autophagy reagents, CD markers, epitope tag antibodies, immunology antibodies, neuroscience antibodies, and veterinary reagents.
Bio-Rad has an ISO 9001 and ISO 13485 certified production facility in the United Kingdom as well as ISO 9001 certified facilities in Germany and the United States.
Our expertise extends to traditional and recombinant antibody generation and production services. Our custom generation service delivers antibodies in as little as 8 weeks with greater than 90% success. The in vitro technology enables selection of antibodies to challenging targets, long term consistent supply, and provision of the antibody sequence.
At Bio-Rad we are committed to your success when using our antibodies and we focus on providing the technology, products and all the supporting information you need to excel in your research.